Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Bicalutamide manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

bicalutamide

Tablets 50 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, PICS, MHRA, WHO
Manufacturer #38657

The company is a pharmaceutical manufacturer engaged in the development, production and export of a range of pharmaceutical products across key therapeutic segments including oncology, critical care and lifesaving medicines, operating with certified manufacturing capabilities and global distribution networks to supply these pharmaceutical products to international healthcare markets.

Manufacturer usually replies in 27 days

bicalutamide

Tablets 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #18975
This contract development and manufacturing organization (CDMO) specializes in producing a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, tablets, and capsules. They cater to clients across the globe, with a strong presence in regions like the EU and North America. Their expertise spans several key therapy areas, utilizing various dosage forms such as oral solid dose. They prioritize quality assurance, adhering to strict GMP certifications and holding numerous product patents.

Manufacturer usually replies in 34 days

bicalutamide

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #10170
A pharmaceutical manufacturer providing export-oriented development and commercial supply of pharmaceutical products across a complete range of finished dosage forms, including tablets, capsules, softgels, injectables, ointments, dry syrups, and sachet presentations. The organisation positions itself as a licensing-and-supply partner with integrated manufacturing expertise and a growing international portfolio, and it reports holding multiple regulatory approvals from major global authorities (including MHRA, TGA, ANVISA and GCC regulators) alongside WHO-GMP compliance for its manufacturing operations, supporting consistent quality and reliability of pharmaceutical products for overseas partners.

Manufacturer usually replies in 29 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

BICALUTAMIDE

Bicalutamide is a hormone therapy. Its combination with gonadotropin-releasing hormone agonists like leuprolide or goserelin Bicalutamide is used to treat metastatic prostate cancer, a cancer that originates in the prostate and spreads to other parts of the body. Bicalutamide belongs to a family of drugs called nonsteroidal antiandrogens, that block the effect of androgen, the male hormone, which stops the growth and spread of cancer cells. It is classified as an "anti-androgen" and is often given in combination with "LHRH agonist," another type of hormone therapy. Bicalutamide is sold as Casodex® amongst other brand names. Imperial Chemical Industries (ICI) discovered Bicalutamide in the 1980s, and first patented it in 1982, following medical use in 1995. It was selected for development from a group of over 2,000 synthesized compounds. In the U.K. it was launched in 1995, it was subsequently approved for the treatment of prostate cancer.

Dosage Forms & Strengths

Bicalutamide is available in the form of a tablet. For treating Prostate cancer, the usual recommended adult dose is 50 mg in combination with LHRH analogue. In the treatment of Locally Advanced Prostate Cancer, the usual recommended adult dose is 150 mg a day as monotherapy.

The price of Bicalutamide

In the USA, consumers have to pay an average retail price of $133 for a supply of 30 tablets of 50mg strength.

How does Bicalutamide Works:

Hormones are chemical substances which are produced by glands in the body and enter the bloodstream and cause effects in other tissues. Male hormones called androgens (primary testosterone) stimulates prostate cancer. This cancer is treated through a hormone therapy, which works by reducing the amount of these hormones in a man with prostate cancer, eventually helping to fight the disease. Testosterone, produced by testicles is responsible for male characteristics like deepening voice and body hair. Hormone therapy works on the principle that receptors for specific hormones that are needed for cell growth are on the surface of tumor cells. This therapy thus aims to stop the production of hormones, block hormone receptors, or substitute chemically similar agents as the active hormone, making it unavailable for use by the tumor cell. Bicalutamide is an Antiandrogen, a substance that blocks the effects of testosterone. Prostate Cancer depends on the male hormone testosterone for its growth, so by reducing it, it is possible to slow down or shrink cancer.

Finding Bicalutamide Manufacturers and Suppliers

The best way to find and gain access to Bicalutamide manufacturers and Bicalutamide suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Bicalutamide can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier.
All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Bicalutamide to work with. You can fine-tune your search results using various filters too, letting you search for Bicalutamide from specific countries, for example.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.